Better Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.6	15.74	40.57	0.12	0.76
Cash & Cash Equivalents	6.6	15.74	40.57	0.12	0.76
Cash Growth	-70.42%	-61.20%	32880.49%	-83.75%	-
Other Current Assets	0.75	2.71	4.69	0.34	0.23
Total Current Assets	7.35	18.45	45.25	0.46	0.99
Property, Plant & Equipment	0.1	0.12	0.08	0.09	0.18
Intangible Assets	14.02	3.89	5.08	5.56	3.27
Other Long-Term Assets	0.48	0.49	0.55	0.28	0.44
Total Long-Term Assets	3.38	4.5	5.71	5.92	3.89
Total Assets	10.72	22.94	50.96	6.39	4.88
Accounts Payable	2.31	3.04	1.52	0.51	0.34
Current Debt	6.59	4.53	0	0	0
Other Current Liabilities	4.04	5.93	3.21	0.1	0.15
Total Current Liabilities	12.94	13.49	4.73	0.61	0.49
Long-Term Debt	7.72	10.35	9.51	0.64	5
Other Long-Term Liabilities	0	0	0	11.89	0
Total Long-Term Liabilities	7.72	10.35	9.51	12.53	5
Total Liabilities	20.66	23.84	14.24	13.15	5.49
Total Debt	14.31	14.88	9.51	0.64	5
Debt Growth	-3.24%	56.55%	1385.16%	-87.20%	-
Common Stock	0	0	0	0	0.21
Retained Earnings	-134.31	-111.5	-71.74	-31.41	-25.02
Shareholders' Equity	-9.94	-0.9	36.72	-6.76	-0.61
Total Liabilities and Equity	10.72	22.94	50.96	6.39	4.88
Net Cash / Debt	-7.71	0.86	31.06	-0.52	-4.24
Net Cash / Debt Growth	-	-97.23%	-	-	-
Net Cash Per Share	-0.20	0.04	1.32	-0.07	-0.18
Working Capital	-5.59	4.95	40.52	-0.15	0.5
Book Value Per Share	-0.26	-0.04	1.56	-0.89	-0.03

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.